Document Detail


Generalisation of ethanol with drug mixtures containing a positive modulator of the GABA(A) receptor and an NMDA antagonist.
MedLine Citation:
PMID:  11077078     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Ethanol is thought to produce its discriminative stimulus effect by actions on two or more neurotransmitter systems. To test this idea further, rats were trained to discriminate mixtures of two drugs from vehicle in two-lever procedures with food reinforcers presented on a tandem variable-interval fixed ratio schedule. After drug-appropriate responding with the training mixtures reached 85%, generalisation to ethanol was examined in extinction tests. Rats trained to discriminate a mixture of chlordiazepoxide (5.0 mg/kg, s. c.) plus dizocilpine (0.08 mg/kg, i.p.) yielded a mean of 76% drug-appropriate responding when tested with ethanol (3.0 g/kg, i.g. ). However, when rats were trained with an 8.0 mg/kg dose of pentobarbitone in a mixture with 0.08 mg/kg of dizocilpine, the same dose of ethanol produced only 33% drug-appropriate responding. After retraining with pentobarbitone (12 mg/kg) plus dizocilpine (0.04 mg/kg), ethanol (3.0 g/kg, i.g.) produced 75% drug-appropriate responding. Pentobarbitone and dizocilpine administered alone produced full, dose-related generalisation, but there was no generalisation to (+)-amphetamine (0.025-0.8 mg/kg, s.c.). Thus, ethanol substituted for mixtures in which the GABA(A)-modulatory component had equal or greater salience than the NMDA-antagonist component. Doses of ethanol that generalised with the drug mixtures always reduced overall rates of responding as compared with control rates. Nevertheless, these data provide further support for the hypothesis that ethanol produces a compound stimulus comprised of elements resembling the effects of positive modulators of GABA(A) receptors and those of NMDA antagonists.
Authors:
I P Stolerman; K Olufsen
Related Documents :
16389668 - Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hy...
1261158 - Blood ethanol concentrations during and following constant-rate intravenous infusion of...
15721488 - Investigation of the mechanisms involved in the central effects of glucagon-like peptid...
9950378 - Intravenous saline has no effect on blood ethanol clearance.
18426348 - Systemic administration of enamel matrix derivative to lipopolysaccharide-challenged pi...
2881568 - Haemodynamic effects of vecuronium, pancuronium and atracurium in patients with coronar...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Neuropharmacology     Volume:  40     ISSN:  0028-3908     ISO Abbreviation:  Neuropharmacology     Publication Date:  2001  
Date Detail:
Created Date:  2001-01-09     Completed Date:  2001-01-09     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0236217     Medline TA:  Neuropharmacology     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  123-30     Citation Subset:  IM    
Affiliation:
Section of Behavioural Pharmacology, Institute of Psychiatry, King's College London, De Crespigny Park, SE5 8AF, London, UK. i.stolerman@iop.kcl.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amphetamine / pharmacology
Animals
Central Nervous System Depressants / pharmacology*
Chlordiazepoxide / pharmacology
Conditioning, Operant / drug effects
Dizocilpine Maleate / pharmacology
Dopamine Uptake Inhibitors / pharmacology
Ethanol / pharmacology*
Excitatory Amino Acid Antagonists / pharmacology
GABA Agonists / pharmacology*
GABA Antagonists / pharmacology*
GABA Modulators / pharmacology
Generalization, Stimulus / drug effects*
Male
Pentobarbital / pharmacology
Rats
Receptors, GABA-A / agonists*
Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors*
Grant Support
ID/Acronym/Agency:
DA05543/DA/NIDA NIH HHS
Chemical
Reg. No./Substance:
0/Central Nervous System Depressants; 0/Dopamine Uptake Inhibitors; 0/Excitatory Amino Acid Antagonists; 0/GABA Agonists; 0/GABA Antagonists; 0/GABA Modulators; 0/Receptors, GABA-A; 0/Receptors, N-Methyl-D-Aspartate; 300-62-9/Amphetamine; 58-25-3/Chlordiazepoxide; 64-17-5/Ethanol; 76-74-4/Pentobarbital; 77086-22-7/Dizocilpine Maleate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  125I-Antisauvagine-30: a novel and specific high-affinity radioligand for the characterization of co...
Next Document:  Effects of postsynaptic GABA(B) receptor activation on epileptiform activity in hippocampal slices.